T. Ganten, R. Koschny, T. Haas, J. Sykora, M. Li‐Weber, K. Herzer, H. Walczak (2005)
Proteasome inhibition sensitizes hepatocellular carcinoma cells, but not human hepatocytes, to TRAILHepatology, 42
H. Yagita, K. Takeda, Y. Hayakawa, M. Smyth, K. Okumura (2004)
TRAIL and its receptors as targets for cancer therapyCancer Science, 95
Chang Xiao, Bao‐feng Yang, Neda Asadi, F. Beguinot, C. Hao (2002)
Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells*The Journal of Biological Chemistry, 277
N. Ishimura, H. Isomoto, S. Bronk, G. Gores (2006)
Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells.American journal of physiology. Gastrointestinal and liver physiology, 290 1
M. MacFarlane, S. Inoue, S. Kohlhaas, A. Majid, N. Harper, D. Kennedy, M. Dyer, M. Dyer, Gerry Cohen (2005)
Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1Cell Death and Differentiation, 12
A. Brandes (2003)
State-of-the-art treatment of high-grade brain tumors.Seminars in oncology, 30 6 Suppl 19
T. Sayers, A. Brooks, C. Koh, Weihong Ma, N. Seki, A. Raziuddin, B. Blazar, Xia Zhang, P. Elliott, W. Murphy (2003)
The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP.Blood, 102 1
R. Koschny, T. Ganten, J. Sykora, T. Haas, M. Sprick, A. Kolb, W. Stremmel, H. Walczak (2007)
TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer‐specific apoptosis within a therapeutic windowHepatology, 45
E. Cheng, M. Wei, S. Weiler, R. Flavell, T. Mak, T. Lindsten, S. Korsmeyer (2001)
BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.Molecular cell, 8 3
T. Ganten, R. Koschny, J. Sykora, H. Schulze‐Bergkamen, P. Büchler, T. Haas, M. Schader, A. Untergasser, W. Stremmel, H. Walczak (2006)
Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic DrugsClinical Cancer Research, 12
K. Ferla-Brühl, M. Westhoff, S. Karl, H. Kasperczyk, R. Zwacka, K. Debatin, S. Fulda (2007)
NF-κB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibitionOncogene, 26
S. Fulda, I. Jeremias, K. Debatin (2004)
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cellsOncogene, 23
T. Ganten, T. Haas, J. Sykora, H. Stahl, M. Sprick, S. Fas, A. Krueger, M. Weigand, A. Grosse‐Wilde, W. Stremmel, P. Krammer, H. Walczak (2004)
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugsCell Death and Differentiation, 11
A. Brooks, Teresa Ramírez, U. Toh, J. Onksen, P. Elliott, W. Murphy, T. Sayers (2005)
The Proteasome Inhibitor Bortezomib (Velcade) Sensitizes Some Human Tumor Cells to Apo2L/TRAIL‐Mediated ApoptosisAnnals of the New York Academy of Sciences, 1059
Amith Panner, C. James, M. Berger, R. Pieper (2005)
mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme CellsMolecular and Cellular Biology, 25
P. Secchiero, M. Vaccarezza, A. Gonelli, G. Zauli (2004)
TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies.Current pharmaceutical design, 10 29
Jin Song, D. Song, B. Pyrzynska, K. Petruk, Erwin Meir, C. Hao (2003)
TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic PathwaysBrain Pathology, 13
P. Kleihues, D. Louis, B. Scheithauer, L. Rorke, G. Reifenberger, P. Burger, W. Cavenee (2002)
The WHO Classification of Tumors of the Nervous SystemJNEN: Journal of Neuropathology & Experimental Neurology, 61
M. Nagane, Guohua Pan, Jessie Weddle, Vishva Dixit, W. Cavenee, H. Huang (2000)
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo.Cancer research, 60 4
R. Zufferey, T. Dull, R. Mandel, A. Bukovsky, Dulce Quiroz, L. Naldini, D. Trono (1998)
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene DeliveryJournal of Virology, 72
P. Pérez-Galán, G. Roué, N. Villamor, E. Montserrat, E. Campo, D. Colomer (2006)
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status.Blood, 107 1
M. Flahaut, A. Mühlethaler-Mottet, K. Auderset, K. Bourloud, R. Meier, M. Popovic, J. Joseph, N. Gross (2006)
Persistent inhibition of FLIPL expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cellsApoptosis, 11
A. Russo, M. Terrasi, V. Agnese, D. Santini, V. Bazan (2006)
Apoptosis: a relevant tool for anticancer therapy.Annals of oncology : official journal of the European Society for Medical Oncology, 17 Suppl 7
A. Ashkenazi, R. Pai, S. Fong, Susan Leung, David Lawrence, S. Marsters, Christine Blackie, Ling Chang, Amy McMurtrey, Andrea Hebert, L. Deforge, I. Koumenis, D. Lewis, Louise Harris, J. Bussiere, H. Koeppen, Z. Shahrokh, R. Schwall (1999)
Safety and antitumor activity of recombinant soluble Apo2 ligand.The Journal of clinical investigation, 104 2
(2005)
Chronic lymphocytic leukemic cells exhibit apoptotic signaling viaTRAIL-R1. Cell Death Differ 2005;12:773^82
A. Kaboré, Jinmie Sun, Xiaojie Hu, Kristin McCrea, J. Johnston, S. Gibson (2006)
The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cellsApoptosis, 11
D. Yin, Hong Zhou, T. Kumagai, Gentao Liu, John Ong, Keith Black, H. Koeffler (2005)
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)Oncogene, 24
L. Naldini, U. Blömer, F. Gage, D. Trono, Inder Verma (1996)
Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Proceedings of the National Academy of Sciences of the United States of America, 93 21
Cancer Epidemiology, Biomarkers and Prevention – Unpaywall
Published: Jun 1, 2007
Access the full text.
Sign up today, get DeepDyve free for 14 days.